News

Dr. Pier Vitale Nuzzo has been recognized for their outstanding work at the recent ESMO Targeted Anticancer Therapies Congress (TAT) 2024 in Paris (26-28 February 2024). 

Dr. Nuzzo received two prestigious awards - the ESMO Merit Travel Grant and the ESMO TAT Award for Best Poster - with the abstract "Targeting de novo lipogenesis synergizes with androgen receptor inhibitors in castration-resistant prostate cancer". 

...

Dr. Loda discusses with Dr. Andrea K. Miyahira (Director of Global Research & Scientific Communications, The Prostate Cancer Foundation) about our latest research article on the role of the microenvironment in prostate cancer progression, published in Nature Communications.

The study focuses on the stroma's significance in prostate carcinogenesis. Utilizing mouse models and human tumors, they performed single-cell RNA sequencing to analyze stromal...

What a great start of the year!

The latest paper from the lab - Distinct mesenchymal cell states mediate prostate cancer progression - has been published on Nature Communications on 08 January 2024! A great collaboration between our lab and many fantastic researchers, including the Marchionni Lab (https://luigimarchionni.org/) and the Multiparametric In Situ Imaging (MISI) Lab (...

Weill Cornell Medicine Loda Lab Belfer Research Building
413 E 69th St
New York, NY 10021 Phone: (646) 962-5042